Cochrane · systematic review · CD013133

Indomethacin for symptomatic patent ductus arteriosus in preterm infants

Evans, P, O'Reilly, D, Flyer, JN, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

NeonatalAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
7
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 4 · 57.1%Moderate 2 · 28.6%High 1 · 14.3%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Indomethacin compared to placebo or control for symptomatic patent ductus arteriosus in preterm infants

Population: symptomatic patent ductus arteriosus in preterm infants
7 questions
OutcomeEffectEvidenceStatus / GRADE
Failure of PDA closure within 1 week of administration of the first dose of indomethacin
Indomethacin vs placebo or control
RR 0.3 [0.23, 0.38]10 studies · 654 participantsHigh
Bronchopulmonary dysplasia at 28 days
Indomethacin vs placebo or control
RR 1.45 [0.6, 3.51]1 study · 55 participantsLow
Downgraded: imprecision
Bronchopulmonary dysplasia at 36 weeks' gestation
Indomethacin vs placebo or control
RR 0.8 [0.41, 1.55]1 study · 92 participantsLow
Downgraded: imprecision
All‐cause neonatal mortality before hospital discharge
Indomethacin vs placebo or control
RR 0.78 [0.46, 1.33]8 studies · 314 participantsModerate
Downgraded: imprecision
Proportion of infants requiring surgical ligation of PDA
Indomethacin vs placebo or control
RR 0.66 [0.33, 1.29]7 studies · 275 participantsModerate
Downgraded: imprecision
NEC (≥ Bell stage 2)
Indomethacin vs placebo or control
RR 1.27 [0.36, 4.55]2 studies · 147 participantsLow
Downgraded: imprecision
Mucocutaneous or gastrointestinal bleeding
Indomethacin vs placebo or control
RR 0.33 [0.01, 7.58]2 studies · 119 participantsLow
Downgraded: imprecision